vs

Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

OMNICELL, INC. is the larger business by last-quarter revenue ($309.9M vs $289.7M, roughly 1.1× ESCO TECHNOLOGIES INC). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs 3.7%, a 6.2% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs 14.9%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $38.6M). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs 5.8%).

Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

ESE vs OMCL — Head-to-Head

Bigger by revenue
OMCL
OMCL
1.1× larger
OMCL
$309.9M
$289.7M
ESE
Growing faster (revenue YoY)
ESE
ESE
+2.3% gap
ESE
17.3%
14.9%
OMCL
Higher net margin
ESE
ESE
6.2% more per $
ESE
9.9%
3.7%
OMCL
More free cash flow
ESE
ESE
$24.3M more FCF
ESE
$63.0M
$38.6M
OMCL
Faster 2-yr revenue CAGR
ESE
ESE
Annualised
ESE
7.8%
5.8%
OMCL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ESE
ESE
OMCL
OMCL
Revenue
$289.7M
$309.9M
Net Profit
$28.7M
$11.4M
Gross Margin
41.4%
45.3%
Operating Margin
13.2%
60.1%
Net Margin
9.9%
3.7%
Revenue YoY
17.3%
14.9%
Net Profit YoY
22.2%
EPS (diluted)
$1.11
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESE
ESE
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$289.7M
$314.0M
Q3 25
$286.5M
$310.6M
Q2 25
$296.3M
$290.6M
Q1 25
$265.5M
$269.7M
Q4 24
$247.0M
$306.9M
Q3 24
$298.5M
$282.4M
Q2 24
$260.8M
$276.8M
Net Profit
ESE
ESE
OMCL
OMCL
Q1 26
$11.4M
Q4 25
$28.7M
Q3 25
$218.7M
$5.5M
Q2 25
$26.1M
$5.6M
Q1 25
$31.0M
$-7.0M
Q4 24
$23.5M
Q3 24
$34.3M
$8.6M
Q2 24
$29.2M
$3.7M
Gross Margin
ESE
ESE
OMCL
OMCL
Q1 26
45.3%
Q4 25
41.4%
41.5%
Q3 25
45.9%
43.3%
Q2 25
41.2%
43.9%
Q1 25
41.1%
41.1%
Q4 24
39.8%
46.2%
Q3 24
40.1%
43.3%
Q2 24
39.6%
41.3%
Operating Margin
ESE
ESE
OMCL
OMCL
Q1 26
60.1%
Q4 25
13.2%
0.1%
Q3 25
17.2%
2.7%
Q2 25
11.2%
2.8%
Q1 25
15.3%
-4.3%
Q4 24
11.4%
4.0%
Q3 24
14.8%
2.3%
Q2 24
14.3%
1.2%
Net Margin
ESE
ESE
OMCL
OMCL
Q1 26
3.7%
Q4 25
9.9%
Q3 25
76.3%
1.8%
Q2 25
8.8%
1.9%
Q1 25
11.7%
-2.6%
Q4 24
9.5%
Q3 24
11.5%
3.1%
Q2 24
11.2%
1.3%
EPS (diluted)
ESE
ESE
OMCL
OMCL
Q1 26
$0.25
Q4 25
$1.11
$-0.05
Q3 25
$8.43
$0.12
Q2 25
$1.01
$0.12
Q1 25
$1.20
$-0.15
Q4 24
$0.91
$0.34
Q3 24
$1.32
$0.19
Q2 24
$1.13
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESE
ESE
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$103.8M
$239.2M
Total DebtLower is stronger
$145.5M
Stockholders' EquityBook value
$1.6B
$1.3B
Total Assets
$2.4B
$2.0B
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESE
ESE
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$103.8M
$196.5M
Q3 25
$101.3M
$180.1M
Q2 25
$78.7M
$399.0M
Q1 25
$57.4M
$386.8M
Q4 24
$71.3M
$369.2M
Q3 24
$66.0M
$570.6M
Q2 24
$63.0M
$556.8M
Total Debt
ESE
ESE
OMCL
OMCL
Q1 26
Q4 25
$145.5M
Q3 25
$186.0M
Q2 25
$525.0M
Q1 25
$88.0M
Q4 24
$112.0M
Q3 24
$122.0M
Q2 24
$173.0M
Stockholders' Equity
ESE
ESE
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$1.6B
$1.2B
Q3 25
$1.5B
$1.2B
Q2 25
$1.3B
$1.3B
Q1 25
$1.3B
$1.3B
Q4 24
$1.2B
$1.2B
Q3 24
$1.2B
$1.2B
Q2 24
$1.2B
$1.2B
Total Assets
ESE
ESE
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$2.4B
$2.0B
Q3 25
$2.4B
$1.9B
Q2 25
$2.5B
$2.1B
Q1 25
$1.8B
$2.2B
Q4 24
$1.8B
$2.1B
Q3 24
$1.8B
$2.3B
Q2 24
$1.8B
$2.3B
Debt / Equity
ESE
ESE
OMCL
OMCL
Q1 26
Q4 25
0.09×
Q3 25
0.12×
Q2 25
0.40×
Q1 25
0.07×
Q4 24
0.09×
Q3 24
0.10×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESE
ESE
OMCL
OMCL
Operating Cash FlowLast quarter
$68.9M
$54.5M
Free Cash FlowOCF − Capex
$63.0M
$38.6M
FCF MarginFCF / Revenue
21.7%
12.5%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
2.40×
4.80×
TTM Free Cash FlowTrailing 4 quarters
$239.6M
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESE
ESE
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$68.9M
$30.4M
Q3 25
$109.9M
$28.3M
Q2 25
$73.7M
$42.8M
Q1 25
$24.1M
$25.9M
Q4 24
$34.2M
$56.3M
Q3 24
$72.1M
$22.8M
Q2 24
$36.2M
$58.7M
Free Cash Flow
ESE
ESE
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$63.0M
$22.6M
Q3 25
$97.8M
$18.5M
Q2 25
$64.9M
$31.0M
Q1 25
$14.0M
$14.8M
Q4 24
$29.0M
$47.2M
Q3 24
$60.9M
$13.9M
Q2 24
$27.6M
$49.1M
FCF Margin
ESE
ESE
OMCL
OMCL
Q1 26
12.5%
Q4 25
21.7%
7.2%
Q3 25
34.1%
6.0%
Q2 25
21.9%
10.7%
Q1 25
5.3%
5.5%
Q4 24
11.7%
15.4%
Q3 24
20.4%
4.9%
Q2 24
10.6%
17.8%
Capex Intensity
ESE
ESE
OMCL
OMCL
Q1 26
Q4 25
2.0%
2.5%
Q3 25
4.2%
3.1%
Q2 25
3.0%
4.1%
Q1 25
3.8%
4.1%
Q4 24
2.1%
3.0%
Q3 24
3.8%
3.1%
Q2 24
3.3%
3.5%
Cash Conversion
ESE
ESE
OMCL
OMCL
Q1 26
4.80×
Q4 25
2.40×
Q3 25
0.50×
5.18×
Q2 25
2.83×
7.58×
Q1 25
0.78×
Q4 24
1.46×
Q3 24
2.10×
2.64×
Q2 24
1.24×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESE
ESE

US Government$98.0M34%
Utility Solutions Group$87.5M30%
RF Shielding And Test$58.3M20%
Commercial$45.8M16%
Related Party$1.3M0%

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons